Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $424.8 million.

  • Pediatrix Medical's Operating Expenses fell 1100.01% to $424.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 2260.78%. This contributed to the annual value of $2.1 billion for FY2024, which is 474.57% up from last year.
  • As of Q3 2025, Pediatrix Medical's Operating Expenses stood at $424.8 million, which was down 1100.01% from $409.0 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Operating Expenses peaked at $662.0 million during Q2 2024, and registered a low of $409.0 million during Q2 2025.
  • In the last 5 years, Pediatrix Medical's Operating Expenses had a median value of $443.1 million in 2022 and averaged $465.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 4643.88% in 2024, then crashed by 3822.28% in 2025.
  • Over the past 5 years, Pediatrix Medical's Operating Expenses (Quarter) stood at $430.5 million in 2021, then rose by 10.98% to $477.8 million in 2022, then rose by 27.23% to $607.9 million in 2023, then decreased by 23.83% to $463.1 million in 2024, then decreased by 8.26% to $424.8 million in 2025.
  • Its Operating Expenses was $424.8 million in Q3 2025, compared to $409.0 million in Q2 2025 and $426.3 million in Q1 2025.